港股異動︱融創中國漲逾3%領漲國指 擬斥153億元收購目標公司股權 獲大行看好
格隆匯11月28日丨融創中國(1918.HK)現報39.2港元,漲3.02%暫領漲國指,暫成交6.8億港元,最新總市值1741億港元。融創昨日盤後發公告稱,擬152.69億元(人民幣,下同)收購環球世紀及時代環球各51%股權,獲得優質土地儲備。目標公司及其附屬公司主要從事地產項目的開發運營,在成都、武漢、長沙、昆明等城市共開發18個目標項目,總建築面積約為3071.6萬平方米。大摩今日發研報指,相信項目具較高的盈利能力,且完成交易後負債比率將降低,認為交易反映公司有很強的併購能力,可為融創帶來競爭優勢,故認為公司為其首選。相信融創中國股價會在15日內上升,發生的可能性達70%-80%,予“增持”評級,目標價55.72港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.